TOP-04

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameTOP-04
Drug Alias NameTOP-4TOP-04
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsOcular inflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTOPIGEN Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTOPIGEN Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsOcular inflammation

Other Information

ATC CodeN/A
Related LinksN/A